Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimicrobial pharmacodynamics.

P G Ambrose1, R C Owens, D Grasela

  • 1University of the Pacific School of Pharmacy, Stockton, California, USA.

The Medical Clinics of North America
|January 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches.

Antimicrobial agents and chemotherapy·2023
Same author

Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber <i>In Vitro</i> Infection Model.

Antimicrobial agents and chemotherapy·2023
Same author

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints.

Antimicrobial agents and chemotherapy·2022
Same author

Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected Patients.

Antimicrobial agents and chemotherapy·2021
Same author

Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.

Antimicrobial agents and chemotherapy·2019
Same author

Population pharmacokinetic analysis for a single 1,200-milligram dose of oritavancin using data from two pivotal phase 3 clinical trials.

Antimicrobial agents and chemotherapy·2015
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Optimizing antimicrobial therapy requires understanding clinical, microbiologic, and pharmacologic data. Pharmacodynamics guides dosing strategies to maximize antibiotic efficacy and minimize patient toxicity for better outcomes.

Area of Science:

  • Pharmacology and Microbiology
  • Clinical Therapeutics

Background:

  • Antimicrobial therapy aims for optimal patient outcomes.
  • Effective treatment necessitates integrating clinical, microbiologic, pharmacologic, and epidemiologic data.
  • Fundamental pharmacodynamic principles are crucial for designing effective antimicrobial dosing strategies.

Purpose of the Study:

  • To highlight the importance of pharmacodynamic principles in antimicrobial therapy.
  • To explain how understanding drug-host-pathogen interactions optimizes treatment.
  • To underscore the role of data in advancing antimicrobial dosing strategies.

Main Methods:

  • Review of accumulated data from in vitro and animal infection models.
  • Analysis of healthy volunteer studies and clinical trials.

Related Experiment Videos

  • Synthesis of knowledge on antimicrobial pharmacodynamics and clinical outcomes.

    • Main Results:

    • Pharmacodynamic principles form the scientific basis for optimizing antimicrobial dosing.
    • Data from various study types have expanded knowledge on antimicrobial efficacy.
    • Clinicians can now establish optimal antibiotic administration modes to maximize microbial killing.

    Conclusions:

    • Understanding pharmacodynamics is essential for maximizing clinical efficacy and minimizing toxicity in antimicrobial therapy.
    • Knowledge gained has enabled improved antibiotic administration strategies.
    • Optimized antimicrobial dosing leads to better patient outcomes.